0000899243-16-013384.txt : 20160216
0000899243-16-013384.hdr.sgml : 20160215
20160216164543
ACCESSION NUMBER: 0000899243-16-013384
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160211
FILED AS OF DATE: 20160216
DATE AS OF CHANGE: 20160216
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ARCA biopharma, Inc.
CENTRAL INDEX KEY: 0000907654
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 363855489
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11080 CIRCLEPOINT ROAD
STREET 2: SUITE 140
CITY: WESTMINSTER
STATE: CO
ZIP: 80020
BUSINESS PHONE: 720-940-2200
MAIL ADDRESS:
STREET 1: 11080 CIRCLEPOINT ROAD
STREET 2: SUITE 140
CITY: WESTMINSTER
STATE: CO
ZIP: 80020
FORMER COMPANY:
FORMER CONFORMED NAME: NUVELO INC
DATE OF NAME CHANGE: 20030203
FORMER COMPANY:
FORMER CONFORMED NAME: HYSEQ INC
DATE OF NAME CHANGE: 19970610
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MITCHELL DANIEL J
CENTRAL INDEX KEY: 0001113661
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-22873
FILM NUMBER: 161429597
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2016-02-11
0
0000907654
ARCA biopharma, Inc.
ABIO
0001113661
MITCHELL DANIEL J
C/O ARCA BIOPHARMA, INC.
11080 CIRCLEPOINT ROAD, SUITE 140
WESTMINSTER
CO
80020
1
0
0
0
Stock Option (right to buy)
3.44
2016-02-11
4
A
0
8000
0.00
A
2026-02-10
Common Stock
8000
8000
D
Grant to the Reporting Person of a stock option under the 2013 Equity Incentive Plan, vesting in 12 equal monthly installments beginning as of January 1, 2016. If the Reporting Person's service as a director of the Issuer terminates in connection with or at any time following a change in control (for whatever reason), then any unexpired options that remain unvested shall become fully vested.
/s/ Brian L. Selby, Attorney-in-Fact
2016-02-16